Learned Intermediary Doctrine in Florida: What Patients Need to Know
If a prescription drug or implanted medical device injured you, Florida’s learned intermediary doctrine decides much of what happens next. Under the doctrine, the manufacturer’s duty to warn runs to your prescribing doctor, not to you. A failure-to-warn claim therefore turns on what the manufacturer told the physician and what the physician would have done with better information. At Calil Law, led by a Board Certified Civil Trial Lawyer with more than 18 years of Florida experience, we build these claims around exactly that question, and the rest of this page explains how it works.
TL;DR
- Florida treats the prescribing physician as the person the manufacturer must warn. A warning that reaches the physician generally satisfies the manufacturer’s duty, even if you never saw it.
- To win a failure-to-warn claim, you must show the warning was inadequate, that the inadequacy caused your injury, and that you were injured by the product.
- Causation is the battleground. If your doctor already knew the risk, or would have prescribed or implanted the product anyway, the claim can fail.
- Claims based on other theories, such as representations made directly to you, can be analyzed separately from the warning claim.
- Medical records and your treating physician’s testimony usually decide these cases, so start gathering them early.
Table of Contents
- What the doctrine says
- Where Florida law comes from
- What you must prove in a Florida failure-to-warn claim
- A worked example: the Salinero decision
- Other theories that may sit beside a warning claim
- Fault, timing and the other rules that apply
- Records that carry these cases
- Why the doctrine calls for a trial lawyer
- Perspective
- Talk to us about your claim
- FAQ
- Sources
What the doctrine says
The usual rule in product cases is that a manufacturer must warn the person who uses the product. Prescription medicine is different. You cannot buy it without a physician’s involvement, so the law treats the physician as an intermediary: the one who weighs benefits against dangers and advises you.
The Florida Bar Journal describes the rationale in just those terms: patients do not get prescription medicines without a physician, so the physician takes on responsibility for explaining the risks. If the manufacturer gave the physician adequate information, it is treated as having met its duty, even if the physician did not pass the information on to you.
The phrase itself dates to a 1966 federal decision, Sterling Drug v. Cornish, according to the Food and Drug Law Institute’s analysis of a leading Florida case.
Where Florida law comes from
Florida courts have applied the doctrine for decades. The Fifth District Court of Appeal recognized it in 1981 in Buckner v. Allergan Pharmaceuticals, holding that a manufacturer’s duty is met by an adequate warning to the medical professionals who prescribe, dispense and administer the drug. The Florida Supreme Court acknowledged the doctrine in 1989 in Felix v. Hoffmann-LaRoche, reasoning that the prescribing physician is the one who weighs the potential benefits against the dangers. Both holdings are quoted in the Eleventh Circuit’s opinion in Salinero v. Johnson & Johnson, decided in 2021.
The Eleventh Circuit is the federal appeals court that covers Florida, so its decisions guide the federal trial courts where many drug and device cases are heard. A Florida lawyer handling one of these claims has to know both the state decisions and the federal ones.
The American Bar Association’s 2025 overview of recent learned intermediary developments adds a point worth knowing: the doctrine can protect a manufacturer even when the physician learned of the risk from some source other than the manufacturer. What counts is whether the physician knew, not who told them.

What you must prove in a Florida failure-to-warn claim
A failure-to-warn claim has three parts. As the Eleventh Circuit stated them in Salinero, you must show:
- The product’s warning was inadequate.
- The inadequacy proximately caused your injury. “Proximate cause” means the missing or weak warning was a real link in the chain that led to the harm, not just a background fact.
- You were actually injured by using the product.
The FDLI analysis adds the traditional standard from the Restatement (Second) of Torts: the manufacturer knew or should have known of the danger, gave an inadequate warning, and a proper warning would have avoided the harm.
Inadequate warning
This is the part most people picture. The label, package insert or instructions for use left out a risk, understated it, or buried it. Proving it takes the product’s labeling history, what the manufacturer knew and when, and the clinical literature. These are documents and experts, not just your own account.
Causation through your doctor
Because the warning is aimed at your physician, causation runs through your physician. In a device case, the Eleventh Circuit explained that you generally must show your treating physician would not have used the product had an adequate warning been given. The chain can break if the physician already knew the risks or would have used the product regardless.
The FDLI describes how sharp this can be: where a prescriber never read the label, the warning’s content cannot be shown to have mattered, and the claim ended on proximate cause regardless of what the label said.
A worked example: the Salinero decision
In Salinero, a patient sued over a mesh implant. The treating surgeon testified that he knew the risks and would have used the device even with improved instructions. The Eleventh Circuit held that, on that testimony, the inadequate-warning theory could not be the proximate cause of the injuries, and the doctrine defeated the failure-to-warn claim. The court also rejected an argument that a surgeon’s financial ties to the manufacturer create an exception.

What this means for you: the physician’s deposition is often the most important testimony in the case. What the doctor read, what the doctor knew, and how the doctor would have acted on a stronger warning are the facts the claim is built on. Preparing that testimony carefully, and knowing early what your doctor is likely to say, shapes whether a warning claim is worth bringing.
Other theories that may sit beside a warning claim
The doctrine does not make every claim about a drug or device a warning claim, and courts separate the theories.
In Mink v. Smith & Nephew (11th Cir. 2017), the Eleventh Circuit held that under Florida law the doctrine barred a theory that the manufacturer negligently trained the surgeon. The same decision held that a misrepresentation claim based on statements made directly to the patient was not expressly preempted by federal device law, because it did not add new safety or effectiveness requirements. Preemption means federal law displaces a state-law claim, and the Supreme Court’s decision in Riegel v. Medtronic limits it to state requirements that differ from or add to federal ones.
In practice, a careful claim looks at the full set of facts: what was said to the physician, what was said to you, how the product was designed and made, and how it performed. A product-liability case may rest on a defect theory rather than on the warning alone. Our guide to Florida product liability law covers the time limits and fault rules that apply, and our page on failure to warn claims explains the claim in more detail.
Pharmacies raise a separate question, since Florida decisions have addressed whether the doctrine shields a pharmacy filling a prescription. The outcome depends on the facts of the case and the court, and it is a point to review with a lawyer before assuming either way.
Fault, timing and the other rules that apply
The doctrine is only one layer. A Florida injury claim also runs through rules on shared fault, deadlines and who can be sued. If a jury finds you partly at fault, Florida’s comparative negligence rules can reduce or bar recovery, and the 12-year repose and 50% fault bar discussed in our product liability guide are worth reading before you wait on a decision.
If the injury came from the way your doctor prescribed, monitored or implanted something, rather than from the manufacturer’s warning, that may be a different claim. Our medical malpractice page explains how those cases work. Sometimes both questions arise in the same set of facts, and sorting them out is the first job.
Records that carry these cases
A drug or device claim is document-heavy. Start with:
- The prescription or surgical record showing the product, dose or model, and dates.
- The packaging, patient leaflet and any device identification card you received.
- Your own notes on what your doctor told you and when your symptoms began.
- Records of the injury, treatment and costs since.
- Any recall notice or safety communication about the product.
Our guide to medical records in an injury claim explains how to request them, and medical liens can affect what you keep from a recovery.
Why the doctrine calls for a trial lawyer
Because the claim often succeeds or fails on one physician’s testimony and one expert’s reading of a label, these cases are not paperwork exercises. They are decided by who presents the causation evidence more convincingly, and many are tried before a jury or decided on a motion that tests that evidence. Calil Law is a Florida litigation firm built around trying high-stakes disputes to verdict, and Calil Law’s lead attorney is a Board Certified Civil Trial Lawyer and Supreme Court Certified Mediator. That combination matters when the question is not only whether you were hurt, but how to prove the chain from warning to physician to injury.
Perspective
When someone is hurt by a medicine or device they trusted, the first instinct is to ask why nobody told them. The doctrine answers a different question: who had to be told. That sounds like a closed door, but it is really a map of where the case is won.
We approach these claims by working backward from the physician. What did the doctor know, what did the manufacturer say, and what would a stronger warning have changed? Those answers decide whether a failure-to-warn claim is the right claim, or whether the strongest path runs through another theory.
Our approach is personal review of each case and direct access to the attorneys handling it. You should never feel you are guessing about where your claim stands. Your life has value, and you deserve a clear explanation of how Florida law treats what happened to you.
Jorge
Talk to us about your claim
If you were hurt by a prescription drug or medical device in Florida, we can review what happened and explain how the learned intermediary doctrine applies to your facts. We represent injured people on a contingency fee basis: no upfront fees, and we are paid only when you receive a settlement or award. You can start on our personal injury page.

If you are unsure whether your situation is a product claim, a medical negligence claim or both, our personal injury overview is a good place to see how these claims fit together.
FAQ
Does the learned intermediary doctrine mean I cannot sue a drug maker in Florida?
No. It changes who the manufacturer had to warn and how you prove causation. If the manufacturer’s warning to physicians was inadequate and a better warning would have changed your doctor’s decision, a claim can still be viable. Other theories, such as defects or direct misrepresentations, are analyzed separately.
Does it matter that I was never told about the risk?
It matters, but the legal focus is on the physician. Under the doctrine, a manufacturer that adequately warned the physician has generally met its duty even if the physician did not tell you, as described by the Florida Bar Journal. Your account of what you were and were not told can still help explain the full picture.
What if my doctor already knew about the risk?
Then causation becomes the central issue. Courts have held that if the treating physician knew the risk or would have used the product anyway, an inadequate warning is not the proximate cause of the injury, as in the Eleventh Circuit’s Salinero decision. Reviewing the physician’s likely testimony early helps judge the claim honestly.
Is the doctrine the same in every state?
It is widely accepted. A 2024 survey by a law-firm blog reported that it applies in all fifty states, but the details differ from state to state. This article describes Florida law and the Eleventh Circuit’s treatment of it. Your case turns on Florida decisions and the facts of your treatment.
How much does it cost to have my case reviewed?
Calil Law works on a contingency fee: no upfront fees are charged, and the firm’s fee is collected from a settlement or court award.
Sources
- The Learned Intermediary Doctrine in Florida: Courts Wrestle with Claimed Exceptions, The Florida Bar Journal
- Salinero v. Johnson & Johnson, U.S. Court of Appeals for the Eleventh Circuit (2021)
- Salinero v. Johnson & Johnson et al., Food and Drug Law Institute (2022)
- Mink v. Smith & Nephew, Inc., 860 F.3d 1319 (11th Cir. 2017)
- Just What the Doctor Ordered: Recent Developments in the Learned Intermediary Doctrine, American Bar Association (2025)